Charnwood Discovery

Executive Summary

Charnwood Discovery is a UK-based contract research organization (CRO) specializing in integrated drug discovery services, from target validation to pre-clinical candidate selection. Founded in 1999, it offers expertise in chemistry, bioscience, and ADME/DMPK, serving pharmaceutical and biotechnology companies. Following its acquisition by Concept Life Sciences in late 2024, Charnwood Discovery is now part of a larger group with expanded resources and capabilities. The company operates out of Loughborough, UK, and continues to provide end-to-end support for drug development programs. Its long-standing presence and comprehensive service suite position it as a reliable partner in the competitive CRO landscape, though further growth will depend on integration success and market demand.

Upcoming Catalysts (preview)

• TBDIntegration with Concept Life Sciences leading to new service offerings70% success
• TBDAnnouncement of major contract wins with pharma/biotech clients60% success